The Global Health Body Issues Concern Over Acute Lack of Obesity Medications

Less than a tenth of people eligible to benefit from obesity jabs such as Wegovy are able to get them, caution the World Health Organization as it publishes its initial guidance on the medications.

Considering in excess of 1,000,000,000 people worldwide currently obese, it is advocating for more widespread and fairer availability to GLP-1 medication.

Based on forecasts, over two billion are projected to be living with obesity by 2030 if no action is taken.

"Our latest guidelines affirms that excess weight is a long-term condition that can be managed with thorough and ongoing support," said WHO director-general Tedros Adhanom Ghebreyesus.

High costs, insufficient output, and supply-chain constraints are major obstacles to widespread availability to the treatments that can assist patients in reducing substantial body mass, explains the agency.

GLP-1 Therapy Shortage

Despite the current best projected scenario, the supply of GLP-1 therapies might only reach about 100 million people – less than 10% of those who need them, per the health organization.

The recommendation encourages nations and manufacturers to increase access, via strategies such as patent sharing.

A patent on a key compound – the main ingredient of a leading brand – is due to expire in a number of nations in 2026.

How Obesity Drugs Function

The injections mimick a biological compound to delay gastric emptying, reduce hunger and increase satiety so people reduce food intake.

Individuals typically begin shedding pounds within a few weeks of beginning the once-weekly jabs.

Research indicates patients may regain a significant portion within a year of halting the drug, when their usual food cravings come back.

To be carrying excess weight increases your risk for developing health problems, like diabetes, cardiovascular issues, stroke, and some cancers.

Obesity affects individuals in all nations and was responsible for 3.7 million fatalities worldwide in 2024, according to the WHO.

Arthur Perry
Arthur Perry

Elara Vance is a luxury travel expert with over a decade of experience exploring exclusive destinations worldwide.